In the last 12 months, insiders at ARROWHEAD PHARMACEUTICALS, INC. ($ARWR) filed 189 transactions with the SEC: 8 open-market purchases totaling $145,166 and 131 sales totaling $55,637,985. Net insider sentiment: net selling.
ARROWHEAD PHARMACEUTICALS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Anzalone Christopher Richard (Chief Executive Officer) — 56 transactions totaling $38,466,021
- Hamilton James C (Chief Medical Officer) — 14 transactions totaling $4,901,561
- O'Brien Patrick (COO) — 23 transactions totaling $3,123,349
- Myszkowski Kenneth Allen (Chief Financial Officer) — 10 transactions totaling $2,868,605
- O'Brien Patrick (COO and General Counsel) — 13 transactions totaling $1,876,421
View all SEC Filings for ARROWHEAD PHARMACEUTICALS, INC. (ARWR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 10000 | $64.19 | 236,958.0000 | 140,706,000 | 4.05% | 0.01% |
| Jan. 6, 2026 | Apel Daniel Joseph | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 176,200.0000 | 140,706,000 | 74.11% | 0.05% |
| Jan. 6, 2026 | Hamilton James C | Chief Medical Officer | A | Common Stock | 75000 | $0.00 | 246,958.0000 | 140,706,000 | 43.62% | 0.05% |
| Jan. 6, 2026 | O'Brien Patrick | COO | G | Common Stock | 540 | $0.00 | 474,368.0000 | 140,706,000 | 0.11% | 0.00% |
| Jan. 6, 2026 | O'Brien Patrick | COO | G | Common Stock | 540 | $0.00 | 473,828.0000 | 140,706,000 | 0.11% | 0.00% |
| Jan. 6, 2026 | O'Brien Patrick | COO | G | Common Stock | 540 | $0.00 | 473,288.0000 | 140,706,000 | 0.11% | 0.00% |
| Jan. 6, 2026 | O'Brien Patrick | COO | G | Common Stock | 440 | $0.00 | 472,848.0000 | 140,706,000 | 0.09% | 0.00% |
| Jan. 6, 2026 | O'Brien Patrick | COO | G | Common Stock | 440 | $0.00 | 472,408.0000 | 140,706,000 | 0.09% | 0.00% |
| Jan. 6, 2026 | O'Brien Patrick | COO | A | Common Stock | 75000 | $0.00 | 547,408.0000 | 140,706,000 | 15.88% | 0.05% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 4368 | $61.20 | 520,033.0000 | 140,706,000 | 0.83% | 0.00% |
| Dec. 31, 2025 | O'Brien Patrick | COO | G | Common Stock | 560 | $0.00 | 526,641.0000 | 133,758,000 | 0.11% | 0.00% |
| Dec. 31, 2025 | O'Brien Patrick | COO | G | Common Stock | 560 | $0.00 | 526,081.0000 | 133,758,000 | 0.11% | 0.00% |
| Dec. 31, 2025 | O'Brien Patrick | COO | G | Common Stock | 560 | $0.00 | 525,521.0000 | 133,758,000 | 0.11% | 0.00% |
| Dec. 31, 2025 | O'Brien Patrick | COO | G | Common Stock | 560 | $0.00 | 524,961.0000 | 133,758,000 | 0.11% | 0.00% |
| Jan. 2, 2026 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 5771 | $66.39 | 3,792,739.0000 | 140,706,000 | 0.15% | 0.00% |
| Jan. 2, 2026 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 7416 | $65.88 | 3,798,510.0000 | 140,706,000 | 0.19% | 0.01% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 309 | $68.00 | 171,958.0000 | 140,706,000 | 0.18% | 0.00% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 437 | $65.97 | 172,267.0000 | 140,706,000 | 0.25% | 0.00% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 1200 | $64.49 | 172,704.0000 | 140,706,000 | 0.69% | 0.00% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 12711 | $63.95 | 173,904.0000 | 140,706,000 | 6.81% | 0.01% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 14792 | $63.01 | 186,615.0000 | 140,706,000 | 7.34% | 0.01% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 6090 | $62.28 | 201,407.0000 | 140,706,000 | 2.93% | 0.00% |
| Jan. 5, 2026 | Hamilton James C | Chief Medical Officer | S | Common Stock | 4625 | $61.24 | 207,497.0000 | 140,706,000 | 2.18% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 46 | $68.00 | 474,908.0000 | 140,706,000 | 0.01% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 2336 | $64.04 | 474,954.0000 | 140,706,000 | 0.49% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 5873 | $62.91 | 477,290.0000 | 140,706,000 | 1.22% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 900 | $62.25 | 483,163.0000 | 140,706,000 | 0.19% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 600 | $61.12 | 484,063.0000 | 140,706,000 | 0.12% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 313 | $68.00 | 484,663.0000 | 140,706,000 | 0.06% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 900 | $66.01 | 484,976.0000 | 140,706,000 | 0.19% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 2700 | $64.44 | 485,876.0000 | 140,706,000 | 0.55% | 0.00% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 11842 | $63.84 | 488,576.0000 | 140,706,000 | 2.37% | 0.01% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 13451 | $62.96 | 500,418.0000 | 140,706,000 | 2.62% | 0.01% |
| Jan. 5, 2026 | O'Brien Patrick | COO | S | Common Stock | 6164 | $62.23 | 513,869.0000 | 140,706,000 | 1.19% | 0.00% |
| Dec. 31, 2025 | O'Brien Patrick | COO | G | Common Stock | 560 | $0.00 | 524,401.0000 | 133,758,000 | 0.11% | 0.00% |
| Dec. 26, 2025 | Ferrari Mauro | Director | S | Common Stock | 7530 | $70.00 | 69,053.0000 | 133,758,000 | 9.83% | 0.01% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Common Stock | 35181 | $6.15 | 3,841,107.0000 | 133,758,000 | 0.92% | 0.03% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Common Stock | 16545 | $6.15 | 3,857,652.0000 | 133,758,000 | 0.43% | 0.01% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 35181 | $69.33 | 3,822,471.0000 | 133,758,000 | 0.91% | 0.03% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 16545 | $68.69 | 3,805,926.0000 | 133,758,000 | 0.43% | 0.01% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Stock Option (right to buy Common Stock) | 35181 | $0.00 | 16,545.0000 | 133,758,000 | 68.01% | 0.03% |
| Dec. 29, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Stock Option (right to buy Common Stock) | 16545 | $0.00 | 0.0000 | 133,758,000 | 100.00% | 0.01% |
| Dec. 19, 2025 | OLUKOTUN ADEOYE Y | Director | S | Common Stock | 6083 | $68.04 | 34,427.0000 | 133,758,000 | 15.02% | 0.00% |
| Dec. 19, 2025 | OLUKOTUN ADEOYE Y | Director | S | Common Stock | 827 | $68.48 | 33,600.0000 | 133,758,000 | 2.40% | 0.00% |
| Dec. 19, 2025 | Vakiener Victoria | Director | S | Common Stock | 2799 | $66.63 | 42,964.0000 | 133,758,000 | 6.12% | 0.00% |
| Dec. 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 3979 | $66.67 | 3,827,978.0000 | 133,758,000 | 0.10% | 0.00% |
| Dec. 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 8147 | $68.01 | 3,819,831.0000 | 133,758,000 | 0.21% | 0.01% |
| Dec. 19, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 1319 | $68.48 | 3,818,512.0000 | 133,758,000 | 0.03% | 0.00% |
| Dec. 22, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 10012 | $68.33 | 3,808,500.0000 | 133,758,000 | 0.26% | 0.01% |
| Dec. 22, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 2574 | $68.85 | 3,805,926.0000 | 133,758,000 | 0.07% | 0.00% |
| Dec. 19, 2025 | OLUKOTUN ADEOYE Y | Director | S | Common Stock | 3090 | $66.70 | 40,510.0000 | 133,758,000 | 7.09% | 0.00% |
| Dec. 19, 2025 | Waddill William D. | Director | S | Common Stock | 2416 | $66.66 | 62,514.0000 | 133,758,000 | 3.72% | 0.00% |
| Dec. 19, 2025 | Vakiener Victoria | Director | S | Common Stock | 1960 | $68.39 | 35,723.0000 | 133,758,000 | 5.20% | 0.00% |
| Dec. 19, 2025 | Vakiener Victoria | Director | S | Common Stock | 5281 | $67.97 | 37,683.0000 | 133,758,000 | 12.29% | 0.00% |
| Dec. 19, 2025 | Waddill William D. | Director | S | Common Stock | 500 | $68.53 | 56,563.0000 | 133,758,000 | 0.88% | 0.00% |
| Dec. 19, 2025 | Waddill William D. | Director | S | Common Stock | 5451 | $68.01 | 57,063.0000 | 133,758,000 | 8.72% | 0.00% |
| Dec. 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 1981 | $66.30 | 3,831,957.0000 | 133,758,000 | 0.05% | 0.00% |
| Dec. 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 982 | $65.53 | 3,833,938.0000 | 133,758,000 | 0.03% | 0.00% |
| Dec. 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 35750 | $64.51 | 3,834,920.0000 | 133,758,000 | 0.92% | 0.03% |
| Dec. 17, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 46287 | $63.55 | 3,870,670.0000 | 133,758,000 | 1.18% | 0.03% |
| Dec. 16, 2025 | Waddill William D. | Director | A | Common Stock | 7819 | $0.00 | 64,930.0000 | 133,758,000 | 13.69% | 0.01% |
| Dec. 16, 2025 | OLUKOTUN ADEOYE Y | Director | A | Common Stock | 7819 | $0.00 | 43,600.0000 | 133,758,000 | 21.85% | 0.01% |
| Dec. 16, 2025 | Vakiener Victoria | Director | A | Common Stock | 7819 | $0.00 | 45,763.0000 | 133,758,000 | 20.61% | 0.01% |
| Dec. 16, 2025 | PERRY MICHAEL S | Director | A | Common Stock | 7819 | $0.00 | 123,059.0000 | 133,758,000 | 6.78% | 0.01% |
| Dec. 16, 2025 | Ferrari Mauro | Director | A | Common Stock | 7819 | $0.00 | 76,583.0000 | 133,758,000 | 11.37% | 0.01% |
| Dec. 16, 2025 | Lu Hongbo | Director | A | Common Stock | 7819 | $0.00 | 54,982.0000 | 133,758,000 | 16.58% | 0.01% |
| Dec. 16, 2025 | INGRAM DOUGLAS S | Director | A | Common Stock | 7819 | $0.00 | 46,215.0000 | 133,758,000 | 20.36% | 0.01% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 8416 | $60.51 | 3,962,839.0000 | 133,758,000 | 0.21% | 0.01% |
| Dec. 12, 2025 | Anzalone Christopher Richard | Chief Executive Officer | A | Common Stock | 180000 | $0.00 | 4,101,255.0000 | 133,758,000 | 4.59% | 0.13% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 6661 | $64.29 | 3,922,644.0000 | 133,758,000 | 0.17% | 0.00% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 1000 | $64.96 | 3,921,644.0000 | 133,758,000 | 0.03% | 0.00% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 1300 | $65.77 | 3,920,344.0000 | 133,758,000 | 0.03% | 0.00% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 8476 | $62.94 | 3,929,305.0000 | 133,758,000 | 0.22% | 0.01% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 166 | $66.77 | 3,920,178.0000 | 133,758,000 | 0.00% | 0.00% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 3221 | $67.87 | 3,916,957.0000 | 133,758,000 | 0.08% | 0.00% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 14095 | $62.12 | 3,937,781.0000 | 133,758,000 | 0.36% | 0.01% |
| Dec. 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 100532 | $68.67 | 4,000,723.0000 | 133,758,000 | 2.45% | 0.08% |
| Dec. 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 21321 | $69.28 | 3,979,402.0000 | 133,758,000 | 0.53% | 0.02% |
| Dec. 15, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 8147 | $69.96 | 3,971,255.0000 | 133,758,000 | 0.20% | 0.01% |
| Dec. 16, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 10963 | $61.25 | 3,951,876.0000 | 133,758,000 | 0.28% | 0.01% |
| Dec. 5, 2025 | PERRY MICHAEL S | Director | S | Common Stock | 16250 | $61.03 | 115,240.0000 | 133,758,000 | 12.36% | 0.01% |
| Nov. 28, 2025 | Ferrari Mauro | Director | S | Common Stock | 8750 | $56.39 | 68,764.0000 | 133,758,000 | 11.29% | 0.01% |
| Oct. 1, 2025 | Hamilton James C | Chief Medical Officer | S | Common Stock | 20000 | $35.00 | 212,122.0000 | 133,758,000 | 8.62% | 0.01% |
| Sept. 12, 2025 | Hamilton James C | Chief Medical Officer | S | Common Stock | 15000 | $30.00 | 232,122.0000 | 139,039,000 | 6.07% | 0.01% |
| Sept. 2, 2025 | Hamilton James C | Chief Medical Officer | S | Common Stock | 15000 | $25.00 | 247,122.0000 | 139,039,000 | 5.72% | 0.01% |
| Aug. 13, 2025 | Hamilton James C | Chief Medical Officer | S | Common Stock | 611 | $20.00 | 271,511.0000 | 139,039,000 | 0.22% | 0.00% |
| Aug. 15, 2025 | Hamilton James C | Chief Medical Officer | S | Common Stock | 9389 | $20.00 | 262,122.0000 | 139,039,000 | 3.46% | 0.01% |
| April 11, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 50800 | $11.49 | 3,921,255.0000 | 124,848,000 | 1.28% | 0.04% |
| April 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 35305 | $9.93 | 4,027,072.0000 | 124,848,000 | 0.87% | 0.03% |
| April 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 3400 | $10.75 | 4,023,672.0000 | 124,848,000 | 0.08% | 0.00% |
| April 9, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 1617 | $11.76 | 4,022,055.0000 | 124,848,000 | 0.04% | 0.00% |
| April 10, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 50000 | $10.87 | 3,972,055.0000 | 124,848,000 | 1.24% | 0.04% |
| March 13, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 51425 | $15.07 | 4,062,377.0000 | 124,848,000 | 1.25% | 0.04% |
| March 13, 2025 | Anzalone Christopher Richard | Chief Executive Officer | A | Common Stock | 340000 | $0.00 | 4,113,802.0000 | 124,848,000 | 9.01% | 0.27% |
| March 4, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 133333 | $17.02 | 3,773,802.0000 | 124,848,000 | 3.41% | 0.11% |
| March 3, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 166667 | $18.03 | 3,907,135.0000 | 124,848,000 | 4.09% | 0.13% |
| March 4, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Common Stock | 133333 | $7.75 | 4,073,802.0000 | 124,848,000 | 3.38% | 0.11% |
| March 3, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Stock Option (right to buy Common Stock) | 166667 | $0.00 | 185,059.0000 | 124,848,000 | 47.39% | 0.13% |
| March 3, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Stock Option (right to buy Common Stock) | 133333 | $0.00 | 51,726.0000 | 124,848,000 | 72.05% | 0.11% |
| March 3, 2025 | Anzalone Christopher Richard | Chief Executive Officer | M | Common Stock | 166667 | $7.75 | 3,940,469.0000 | 124,848,000 | 4.42% | 0.13% |
| Feb. 7, 2025 | Anzalone Christopher Richard | Chief Executive Officer | A | Common Stock | 9550 | $20.10 | 3,773,802.0000 | 124,848,000 | 0.25% | 0.01% |
| Feb. 6, 2025 | INGRAM DOUGLAS S | Director | A | Common Stock | 38396 | $20.09 | 38,396.0000 | 124,848,000 | 9999.99% | 0.03% |
| Jan. 23, 2025 | OLUKOTUN ADEOYE Y | Director | S | Common Stock | 959 | $21.00 | 35,781.0000 | 124,848,000 | 2.61% | 0.00% |
| Jan. 6, 2025 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 9526 | $20.10 | 535,201.0000 | 124,848,000 | 1.75% | 0.01% |
| Jan. 4, 2025 | Hamilton James C | Chief Discovery/Trans Medicine | A | Common Stock | 100000 | $0.00 | 304,851.0000 | 124,848,000 | 48.82% | 0.08% |
| Jan. 6, 2025 | Hamilton James C | Chief Discovery/Trans Medicine | S | Common Stock | 21758 | $19.68 | 283,093.0000 | 124,848,000 | 7.14% | 0.02% |
| Jan. 6, 2025 | Hamilton James C | Chief Discovery/Trans Medicine | S | Common Stock | 10971 | $20.11 | 272,122.0000 | 124,848,000 | 3.88% | 0.01% |
| Jan. 4, 2025 | O'Brien Patrick | COO and General Counsel | A | Common Stock | 100000 | $0.00 | 564,385.0000 | 124,848,000 | 21.53% | 0.08% |
| Jan. 6, 2025 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 19658 | $19.69 | 544,727.0000 | 124,848,000 | 3.48% | 0.02% |
| Jan. 7, 2025 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 8000 | $19.69 | 527,201.0000 | 124,848,000 | 1.49% | 0.01% |
| Jan. 4, 2025 | Myszkowski Kenneth Allen | Chief Financial Officer | A | Common Stock | 100000 | $0.00 | 500,600.0000 | 124,848,000 | 24.96% | 0.08% |
| Jan. 6, 2025 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 17765 | $19.68 | 482,835.0000 | 124,848,000 | 3.55% | 0.01% |
| Jan. 6, 2025 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 9402 | $20.10 | 473,433.0000 | 124,848,000 | 1.95% | 0.01% |
| Jan. 7, 2025 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 8000 | $19.70 | 465,433.0000 | 124,848,000 | 1.69% | 0.01% |
| Jan. 7, 2025 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 10000 | $19.69 | 455,433.0000 | 124,848,000 | 2.15% | 0.01% |
| Jan. 2, 2025 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 11520 | $19.05 | 3,764,252.0000 | 124,848,000 | 0.31% | 0.01% |
| Dec. 27, 2024 | OLUKOTUN ADEOYE Y | Director | S | Common Stock | 2850 | $20.00 | 36,740.0000 | 119,784,000 | 7.20% | 0.00% |
| Dec. 23, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 12563 | $19.59 | 3,775,772.0000 | 119,784,000 | 0.33% | 0.01% |
| Dec. 18, 2024 | Waddill William D. | Director | A | Common Stock | 16733 | $22.99 | 57,111.0000 | 119,784,000 | 41.44% | 0.01% |
| Dec. 18, 2024 | Ferrari Mauro | Director | A | Common Stock | 16733 | $22.99 | 77,514.0000 | 119,784,000 | 27.53% | 0.01% |
| Dec. 18, 2024 | PERRY MICHAEL S | Director | A | Common Stock | 16733 | $22.99 | 131,490.0000 | 119,784,000 | 14.58% | 0.01% |
| Dec. 18, 2024 | Lu Hongbo | Director | A | Common Stock | 16733 | $22.99 | 47,163.0000 | 119,784,000 | 54.99% | 0.01% |
| Dec. 18, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 12653 | $20.52 | 3,702,394.0000 | 119,784,000 | 0.34% | 0.01% |
| Dec. 18, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 8260 | $21.74 | 3,694,134.0000 | 119,784,000 | 0.22% | 0.01% |
| Dec. 18, 2024 | Anzalone Christopher Richard | Chief Executive Officer | A | Common Stock | 100000 | $0.00 | 3,788,335.0000 | 119,784,000 | 2.71% | 0.08% |
| Dec. 18, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 5799 | $22.12 | 3,688,335.0000 | 119,784,000 | 0.16% | 0.00% |
| Dec. 18, 2024 | Vakiener Victoria | Director | A | Common Stock | 16733 | $22.99 | 37,944.0000 | 119,784,000 | 78.89% | 0.01% |
| Dec. 18, 2024 | OLUKOTUN ADEOYE Y | Director | A | Common Stock | 16733 | $22.99 | 39,590.0000 | 119,784,000 | 73.21% | 0.01% |
| Dec. 17, 2024 | GIVEN DOUGLAS B | Director | S | Common Stock | 547 | $22.04 | 124,167.0000 | 119,784,000 | 0.44% | 0.00% |
| Dec. 16, 2024 | Waddill William D. | Director | S | Common Stock | 3748 | $21.90 | 44,125.0000 | 119,784,000 | 7.83% | 0.00% |
| Dec. 17, 2024 | Waddill William D. | Director | S | Common Stock | 3747 | $22.04 | 40,378.0000 | 119,784,000 | 8.49% | 0.00% |
| Dec. 16, 2024 | GIVEN DOUGLAS B | Director | S | Common Stock | 5000 | $21.90 | 124,714.0000 | 119,784,000 | 3.85% | 0.00% |
| Dec. 16, 2024 | Vakiener Victoria | Director | S | Common Stock | 8994 | $21.91 | 21,211.0000 | 119,784,000 | 29.78% | 0.01% |
| Sept. 25, 2024 | Lu Hongbo | Director | G | Common Stock | 5650 | $0.00 | 36,080.0000 | 124,199,000 | 13.54% | 0.00% |
| March 22, 2024 | Lu Hongbo | Director | P | Common Stock | 400 | $28.00 | 39,730.0000 | 106,750,000 | 1.02% | 0.00% |
| March 26, 2024 | Lu Hongbo | Director | P | Common Stock | 850 | $27.50 | 40,580.0000 | 106,750,000 | 2.14% | 0.00% |
| April 2, 2024 | Lu Hongbo | Director | P | Common Stock | 150 | $27.34 | 40,730.0000 | 106,750,000 | 0.37% | 0.00% |
| April 10, 2024 | Lu Hongbo | Director | P | Common Stock | 500 | $25.00 | 41,230.0000 | 106,750,000 | 1.23% | 0.00% |
| April 18, 2024 | Lu Hongbo | Director | P | Common Stock | 500 | $22.00 | 41,730.0000 | 106,750,000 | 1.21% | 0.00% |
| July 2, 2024 | Oliver Tracie | Chief Commercial Officer | S | Common Stock | 9394 | $25.28 | 127,107.0000 | 124,199,000 | 6.88% | 0.01% |
| May 2, 2024 | Vakiener Victoria | Director | S | Common Stock | 1799 | $23.31 | 30,205.0000 | 106,750,000 | 5.62% | 0.00% |
| April 1, 2024 | Hamilton James C | Chief Discovery/Trans Medicine | S | Common Stock | 6000 | $28.03 | 204,851.0000 | 106,750,000 | 2.85% | 0.01% |
| March 20, 2024 | Lu Hongbo | Director | P | Common Stock | 1000 | $27.50 | 33,680.0000 | 106,750,000 | 3.06% | 0.00% |
| March 18, 2024 | Lu Hongbo | Director | P | Common Stock | 1000 | $27.49 | 31,680.0000 | 106,750,000 | 3.26% | 0.00% |
| March 19, 2024 | Lu Hongbo | Director | P | Common Stock | 1000 | $28.00 | 32,680.0000 | 106,750,000 | 3.16% | 0.00% |
| March 6, 2024 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 40000 | $35.19 | 400,600.0000 | 106,750,000 | 9.08% | 0.04% |
| Jan. 31, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 19730 | $32.71 | 3,715,048.0000 | 106,750,000 | 0.53% | 0.02% |
| Jan. 31, 2024 | Anzalone Christopher Richard | Chief Executive Officer | M | Common Stock | 57499 | $14.54 | 3,772,547.0000 | 106,750,000 | 1.55% | 0.05% |
| Jan. 31, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 37769 | $32.16 | 3,734,778.0000 | 106,750,000 | 1.00% | 0.04% |
| Jan. 31, 2024 | Anzalone Christopher Richard | Chief Executive Officer | M | Stock Option (right to buy) | 57499 | $0.00 | 351,726.0000 | 106,750,000 | 14.05% | 0.05% |
| Jan. 12, 2024 | Hamilton James C | Chief Discovery/Trans Medicine | S | Common Stock | 3702 | $37.37 | 210,851.0000 | 106,750,000 | 1.73% | 0.00% |
| Jan. 12, 2024 | Hamilton James C | Chief Discovery/Trans Medicine | S | Common Stock | 4238 | $36.47 | 214,553.0000 | 106,750,000 | 1.94% | 0.00% |
| Jan. 11, 2024 | GIVEN DOUGLAS B | Director | S | Common Stock | 1100 | $38.55 | 129,711.0000 | 106,750,000 | 0.84% | 0.00% |
| Jan. 11, 2024 | Waddill William D. | Director | S | Common Stock | 2634 | $37.81 | 49,170.0000 | 106,750,000 | 5.08% | 0.00% |
| Jan. 11, 2024 | Waddill William D. | Director | S | Common Stock | 1300 | $38.59 | 47,870.0000 | 106,750,000 | 2.64% | 0.00% |
| Jan. 11, 2024 | Ferrari Mauro | Director | S | Common Stock | 2147 | $37.80 | 61,778.0000 | 106,750,000 | 3.36% | 0.00% |
| Jan. 11, 2024 | Ferrari Mauro | Director | S | Common Stock | 1000 | $38.63 | 60,778.0000 | 106,750,000 | 1.62% | 0.00% |
| Jan. 11, 2024 | Vakiener Victoria | Director | S | Common Stock | 3620 | $37.87 | 33,101.0000 | 106,750,000 | 9.86% | 0.00% |
| Jan. 11, 2024 | Vakiener Victoria | Director | S | Common Stock | 1100 | $38.84 | 32,001.0000 | 106,750,000 | 3.32% | 0.00% |
| Jan. 11, 2024 | GIVEN DOUGLAS B | Director | S | Common Stock | 1811 | $37.76 | 130,811.0000 | 106,750,000 | 1.37% | 0.00% |
| Jan. 5, 2024 | San Martin Javier | Chief Medical Officer | S | Common Stock | 800 | $34.11 | 206,000.0000 | 106,750,000 | 0.39% | 0.00% |
| Jan. 5, 2024 | San Martin Javier | Chief Medical Officer | S | Common Stock | 3100 | $35.03 | 202,900.0000 | 106,750,000 | 1.50% | 0.00% |
| Jan. 5, 2024 | San Martin Javier | Chief Medical Officer | S | Common Stock | 4403 | $35.64 | 198,497.0000 | 106,750,000 | 2.17% | 0.00% |
| Jan. 4, 2024 | Oliver Tracie | Chief Commercial Officer | A | Common Stock | 75000 | $0.00 | 136,575.0000 | 106,750,000 | 121.80% | 0.07% |
| Jan. 5, 2024 | Oliver Tracie | Chief Commercial Officer | S | Common Stock | 74 | $33.89 | 136,501.0000 | 106,750,000 | 0.05% | 0.00% |
| Jan. 4, 2024 | Myszkowski Kenneth Allen | Chief Financial Officer | A | Common Stock | 75000 | $0.00 | 456,704.0000 | 106,750,000 | 19.65% | 0.07% |
| Jan. 5, 2024 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 1400 | $34.04 | 455,304.0000 | 106,750,000 | 0.31% | 0.00% |
| Jan. 5, 2024 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 5800 | $34.97 | 449,504.0000 | 106,750,000 | 1.27% | 0.01% |
| Jan. 5, 2024 | Myszkowski Kenneth Allen | Chief Financial Officer | S | Common Stock | 8904 | $35.65 | 440,600.0000 | 106,750,000 | 1.98% | 0.01% |
| Jan. 4, 2024 | San Martin Javier | Chief Medical Officer | A | Common Stock | 75000 | $0.00 | 206,800.0000 | 106,750,000 | 56.90% | 0.07% |
| Jan. 5, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 12741 | $35.65 | 464,385.0000 | 106,750,000 | 2.67% | 0.01% |
| Jan. 3, 2024 | Hamilton James C | Other | S | Common Stock | 3500 | $31.81 | 178,734.0000 | 106,750,000 | 1.92% | 0.00% |
| Jan. 3, 2024 | Hamilton James C | Other | S | Common Stock | 2300 | $32.52 | 176,434.0000 | 106,750,000 | 1.29% | 0.00% |
| Jan. 3, 2024 | Hamilton James C | Other | S | Common Stock | 500 | $33.30 | 175,934.0000 | 106,750,000 | 0.28% | 0.00% |
| Jan. 4, 2024 | Hamilton James C | Other | A | Common Stock | 75000 | $0.00 | 250,934.0000 | 106,750,000 | 42.63% | 0.07% |
| Jan. 5, 2024 | Hamilton James C | Other | S | Common Stock | 1800 | $34.00 | 249,134.0000 | 106,750,000 | 0.72% | 0.00% |
| Jan. 5, 2024 | Hamilton James C | Other | S | Common Stock | 8000 | $34.94 | 241,134.0000 | 106,750,000 | 3.21% | 0.01% |
| Jan. 5, 2024 | Hamilton James C | Other | S | Common Stock | 12343 | $35.65 | 228,791.0000 | 106,750,000 | 5.12% | 0.01% |
| Jan. 5, 2024 | Hamilton James C | Other | S | Common Stock | 10000 | $35.00 | 218,791.0000 | 106,750,000 | 4.37% | 0.01% |
| Jan. 3, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 3849 | $31.83 | 408,726.0000 | 106,750,000 | 0.93% | 0.00% |
| Jan. 3, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 2800 | $32.52 | 405,926.0000 | 106,750,000 | 0.69% | 0.00% |
| Jan. 3, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 400 | $33.41 | 405,526.0000 | 106,750,000 | 0.10% | 0.00% |
| Jan. 3, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 1700 | $32.65 | 403,826.0000 | 106,750,000 | 0.42% | 0.00% |
| Jan. 4, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 1600 | $32.63 | 402,226.0000 | 106,750,000 | 0.40% | 0.00% |
| Jan. 4, 2024 | O'Brien Patrick | COO and General Counsel | A | Common Stock | 85000 | $0.00 | 487,226.0000 | 106,750,000 | 21.13% | 0.08% |
| Jan. 5, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 1900 | $33.99 | 485,326.0000 | 106,750,000 | 0.39% | 0.00% |
| Jan. 5, 2024 | O'Brien Patrick | COO and General Counsel | S | Common Stock | 8200 | $34.99 | 477,126.0000 | 106,750,000 | 1.69% | 0.01% |
| Jan. 2, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 4634 | $30.74 | 3,720,366.0000 | 106,750,000 | 0.12% | 0.00% |
| Jan. 2, 2024 | Anzalone Christopher Richard | Chief Executive Officer | S | Common Stock | 5318 | $31.25 | 3,715,048.0000 | 106,750,000 | 0.14% | 0.00% |